Cost-effectiveness of angiotensin receptor blockers in patients with hypertension: A comparative analysis using clinical trial and observational data

被引：0
|
作者：
Boersma, C. [1 ]
Voors, A. A. [2 ]
Van den Berg, P. B. [1 ]
Visser, S. T. [1 ]
De Jong-van den Berg, L. T. [1 ]
Postma, M. J. [1 ]
机构：
[1] Univ Groningen, NL-9700 AB Groningen, Netherlands
[2] Univ Med Ctr, Groningen, Netherlands
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)65453-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A417 / A417
页数：1
相关论文
共 50 条
  • [1] COST-EFFECTIVENESS OF ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH UNCOMPLICATED HYPERTENSION: A COMPARATIVE ANALYSIS USING CLINICAL AND DRUGS UTILIZATION DATA
    Mazza, A.
    Schiavon, L.
    Rossetti, C.
    Sacco, A. P.
    Bregola, G.
    Contato, E.
    Ramazzina, E.
    JOURNAL OF HYPERTENSION, 2017, 35 : E211 - E211
  • [2] Cost-Effectiveness of Angiotensin Receptor Blockers in Moroccan Patients with Hypertension
    El Azizi, Ghizlane Berrada
    Ahid, Samir
    Abir-Khalili, Saadia
    Ellouali, Fedoua
    El Majha, Amine
    D'Ouzzane, Mouna Charif
    Mouram, Sahar
    Boukili, Abdelali
    Cherti, Mohammed
    Hassar, Mohammed
    Cherrah, Yahia
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 431 - 432
  • [3] Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the Netherlands A Comparative Analysis Using Clinical Trial and Drug Utilization Data
    Boersma, Cornelis
    Voors, Adriaan A.
    Visser, Sipke T.
    de Jong-van den Berg, Lolkje T. W.
    Postma, Maarten J.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2010, 10 (01) : 49 - 54
  • [4] Cost Effectiveness of Angiotensin Receptor Blocker Monotherapy in Patients with Hypertension in the NetherlandsA Comparative Analysis Using Clinical Trial and Drug Utilization Data
    Cornelis Boersma
    Adriaan A. Voors
    Sipke T. Visser
    Lolkje T. W. de Jong-van den Berg
    Maarten J. Postma
    American Journal of Cardiovascular Drugs, 2010, 10 : 49 - 54
  • [5] Cost-benefit effectiveness of angiotensin-II receptor blockers in patients with uncomplicated hypertension: A comparative analysis
    Mazza, Alberto
    Sacco, Antonella Paola
    Townsend, Danyelle M.
    Bregola, Gianni
    Contatto, Edgardo
    Cappello, Isabella
    Schiavon, Laura
    Ramazzina, Emilio
    Rubello, Domenico
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 90 : 665 - 669
  • [6] INCREMENTAL COST-EFFECTIVENESS ANALYSIS OF ANGIOTENSIN RECEPTOR BLOCKERS IN HYPERTENSIVE PATIENTS IN A US MANAGED CARE POPULATION
    Miller, L. A.
    Wade, R.
    Cziraky, M. J.
    Dai, D.
    Mayo, K.
    Ramsawany, K.
    VALUE IN HEALTH, 2009, 12 (03) : A148 - A148
  • [7] A COST-EFFECTIVENESS ANALYSIS BETWEEN AMLODIPINE AND ANGIOTENSIN II RECEPTOR BLOCKERS IN STROKE AND MYOCARDIAL INFARCTION PREVENTION AMONG HYPERTENSION PATIENTS IN CHINA
    Wu, Y.
    Li, M.
    Xuan, J.
    Zelt, S.
    Yin, H.
    Zhou, Q.
    Zhang, C.
    Huang, M.
    VALUE IN HEALTH, 2012, 15 (07) : A631 - A631
  • [8] Bayesian cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    Montmartin, J
    STATISTICS IN MEDICINE, 2001, 20 (05) : 733 - 753
  • [9] A framework for cost-effectiveness analysis from clinical trial data
    O'Hagan, A
    Stevens, JW
    HEALTH ECONOMICS, 2001, 10 (04) : 303 - 315
  • [10] COMPARATIVE EFFECTIVENESS OF INDIVIDUAL ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH CHF
    Desai, R.
    Chen, H.
    Morgan, R.
    Johnson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A142 - A142
12345